In the BioHarmony Drug Report Database

"Preview" Icon

Biperiden

Akineton (biperiden) is a small molecule pharmaceutical. Biperiden was first approved as Akineton on 1982-01-01. It is used to treat parkinson disease in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M1. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M3, and muscarinic acetylcholine receptor M5.

 

Trade Name

 

Akineton
 

Common Name

 

biperiden
 

ChEMBL ID

 

CHEMBL1101
 

Indication

 

parkinson disease
 

Drug Class

 

Image (chem structure or protein)

Biperiden structure rendering